CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Ergocalciferols +1 moredrug
Likely dose
Ergocalciferols 50,000 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01268111
NCT01268111Phase 1Completed
CompareCT.gov

Effect of Vitamin D Supplementation on Insulin Sensitivity and Retinol-binding Protein 4 Levels in Subjects With Vitamin D Deficiency

Texas Tech University Health Sciences Center·interventional·Posted Dec 29, 2010·Updated Jun 8, 2015

In Brief

A Phase 1 clinical trial evaluating Ergocalciferols and Placebo for Insulin Sensitivity. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Sensitivity
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 29, 2010
Enrollment StartJan 1, 2011
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.5 years ago

Interventions

Ergocalciferolsdrug

ERgocaclciferol 50,000 units weekly for 8 weeks

Placebodrug

matching placebo